Status:
UNKNOWN
Risk Stratification of VT / VF After Myocardial Infarction Based on Cardiac MRI 2
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Myocardial Infarction
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
Implantable cardioverter-defibrillators (ICD) are currently recommended (ESC guidelines 2015) for the primary prevention of sudden cardiac death (SCD) in patients with a remote myocardial infarction (...
Eligibility Criteria
Inclusion
- Person who has received full information on the organization of the research and who has not objected to the use of this data;
- Person having had an ICD implantation for primary prevention before 12/31/2017 after myocardial infarction;
- Person with LVEF ≤35% at the time of ICD implantation.
Exclusion
- Patient with a history of persistent atrial fibrillation.
Key Trial Info
Start Date :
July 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT05226234
Start Date
July 15 2022
End Date
December 31 2023
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Nancy, France, 54000